Início › Leucemia Mieloide Aguda › Nebraska › Omaha
Ensaios clínicos de Leucemia Mieloide Aguda em Omaha, NE
10 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Omaha e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · a 9 mi de distância
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · a 9 mi de distância
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · a 9 mi de distância
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecrutandoFase 3
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecrutandoFase 1
- University of Nebraska Medical Center, Omaha
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
RecrutandoFase 2/3
- University of Nebraska Medical Center, Omaha
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- University of Nebraska Medical Center, Omaha
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecrutandoFase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Ensaios de Leucemia Mieloide Aguda em outras cidades
- Houston, TX85 estudos
- New York City, NY51 estudos
- Boston, MA44 estudos
- Baldwin Park, CA40 estudos
- Seattle, WA40 estudos
- Columbus, OH35 estudos
- Philadelphia, PA34 estudos
- Durham, NC33 estudos
- Atlanta, GA30 estudos
- Tampa, FL29 estudos
- Chicago, IL26 estudos
- Portland, OR25 estudos
Outros estudos em Omaha
- Câncer de Próstata27 estudos
- Câncer de Pulmão de Não Pequenas Células24 estudos
- Câncer de Mama22 estudos
- Câncer Colorretal18 estudos
- Câncer (todos os tipos)18 estudos
- Mieloma Múltiplo16 estudos
- Linfoma Não Hodgkin14 estudos
- Câncer de Ovário14 estudos
- Câncer de Pâncreas14 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço13 estudos
- Insuficiência Cardíaca13 estudos
- Câncer Metastático13 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.